ALDH1A1 and endometrial cancer: Immunohistochemical analysis has shown minimal ALDH1 expression in benign proliferative and secretory endometrium, while cytoplasmic ALDH1 expression exhibits a stepwise increase in endometrial hyperplasia, atypical hyperplasia, and endometrial cancer.